EU/3/04/191

Table of contents

About

Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in July 2015 on request of the sponsor.

On 8 March 2004, orphan designation (EU/3/04/191) was granted by the European Commission to Orfagen, France, for ethanol (96 per cent) (gel for injection) for the treatment of congenital venous malformations.

Key facts

Active substance
Ethanol
Disease / condition
Treatment of congenital venous malformations
Date of first decision
09/03/2004
Outcome
Withdrawn
EU designation number
EU/3/04/191

Sponsor's contact details

Orfagen
CRDPF Langlade
3 Avenue Hubert Curien - BP 13562
31035 Toulouse Cedex 1
France
Tel. +33 5345 06459
Fax +33 5345 03457
E-mail: info@orfagen.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating